By Bhanvi Satija and Sriparna Roy Aug 28 (Reuters) - BioNTech SE said it will end a mid-stage study of its experimental mRNA ...

For older adults, the flu vaccine could look a little different this year.

In light of recent wins for mRNA vaccine makers, UCSC RNA Center Co-Director Jeremy Sanford describes the versatility of the ...

The US Food and Drug Administration on Wednesday approved the United States’ first mRNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.

An experimental mRNA vaccine allowed people with high-risk melanoma to live longer, cancer-free, in a large, closely watched ...

The Food and Drug Administration has approved the first-ever mRNA flu vaccine, a shot that will use new technology to target evolving viruses and streamline vaccine production faster than traditional ...

Pharmaceutical partners Moderna and Merck announced on Wednesday that their novel mRNA-based vaccine—individually tailored to ...

Share on Pinterest Moderna’s new mRNA flu vaccine has been approved by the FDA for adults ages 50 years and older. FatCamera, E+/Getty Images The Food and Drug Administration (FDA) has approved ...

Personalized mRNA vaccines are showing promise as a new way to fight cancer, particularly melanoma. The vaccines are designed ...

CAMBRIDGE, MA / ACCESS Newswire / August 27, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and ...

The shot, made by Moderna, will be available for this year's upcoming flu season.